目的 統(tǒng)計(jì)分析2019-2021年天津市寶坻區(qū)人民醫(yī)院保肝藥物的使用情況,分析其使用趨勢(shì),為醫(yī)院保肝藥物的科學(xué)管理和臨床合理用藥提供參考。方法 采用世界衛(wèi)生組織推薦的限定日劑量(DDD)分析方法,計(jì)算每種保肝藥物的用藥頻度(DDDs)、日均費(fèi)用(DDC),并對(duì)藥物的銷售金額和DDDs分別進(jìn)行排序,計(jì)算其排序比(B/A)。結(jié)果 天津市寶坻區(qū)人民醫(yī)院保肝藥物以口服劑型為主,銷售金額與用藥頻度排序比接近1、大于1的品種逐年增多,且使用頻度排名前3位的藥物DDC均小于10元。結(jié)論 天津市寶坻區(qū)人民醫(yī)院臨床對(duì)于保肝藥物的選擇在保證療效的基礎(chǔ)上更加傾向于價(jià)格偏低的品種,符合安全、有效、經(jīng)濟(jì)的用藥原則。

Objective To statistically analyze the use of hepatoprotective drugs in Tianjin Baodi Hospital from 2019 to 2021, and analyze their use trend, so as to provide reference for the scientific management and clinical rational use of liver protecting drugs in the hospital.Methods Using the analysis method of defined daily dose (DDD) recommended by the World Health Organization (WHO), the medication frequency (DDDs) and average daily cost (DDC) of each hepatoprotective drugs were calculated, and the sales amount and DDDs of drugs were ranked, respectively, and the ranking ratio was calculated.Results The hepatoprotective drugs are mainly oral dosage forms. The ranking ratio of sales amount to medication frequency is close to 1, and the varieties greater than 1 are increasing year by year, and the DDC of the top three drugs ranked in the frequency of use is less than 10 yuan.Conclusion On the basis of ensuring the curative effect, the clinical choice of hepatoprotective drugs in Tianjin Baodi Hospital is more inclined to the varieties with low price, which is in line with the principle of safe, effective and economic drug use.

R975